Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03BFU
|
|||
| Drug Name |
Pradaxa
|
|||
| Synonyms |
Dabigatran etexilate mesylate; 872728-81-9; XETBXHPXHHOLOE-UHFFFAOYSA-N; CP0128; FT-0660872; ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate methanesulphonate; 1-methyl-2-[N-[4-(N-n-hexyloxycarbonylamidino)phenyl]-amino-methyl]-benzimidazol-5-yl-carboxylic acid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)-amide mesylate
Click to Show/Hide
|
|||
| Indication | Stroke [ICD-11: 8B20; ICD-10: I64] | Phase 3 | [1], [2] | |
| Company |
Boehringer Ingelheim Pharmaceuticals Ridgefield, CT
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C35H45N7O8S
|
|||
| Canonical SMILES |
CCCCCCOC(=O)N=C(C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)N.CS(=O)(=O)O
|
|||
| InChI |
1S/C34H41N7O5.CH4O3S/c1-4-6-7-10-21-46-34(44)39-32(35)24-12-15-26(16-13-24)37-23-30-38-27-22-25(14-17-28(27)40(30)3)33(43)41(20-18-31(42)45-5-2)29-11-8-9-19-36-29;1-5(2,3)4/h8-9,11-17,19,22,37H,4-7,10,18,20-21,23H2,1-3H3,(H2,35,39,44);1H3,(H,2,3,4)
|
|||
| InChIKey |
XETBXHPXHHOLOE-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 872728-81-9
|
|||
| PubChem Compound ID | ||||
| ADReCS Drug ID | BADD_D00565 | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.